The vaccine can confer up to 100 percent protection and will be tested in 2,100 people on the west African island of Bioko.
Instead of using a single protein from the parasite, researchers are using entire parasites—which come with more than 5,000 proteins—deactivated with low doses of radiation.
Scientists have identified a way to provide more detailed information on malaria transmission both locally and across borders.
The Director of the National Center for Disease Control, Badreddine Bashir al-Najjar, confirmed the case in a four-month-old child, adding that tests were underway to determine how she contracted the disease.
Mosquitoes that landed on surfaces coated with the antimalarial compound atovaquone were completely blocked from developing Plasmodium falciparum (P. falciparum), the parasite that causes malaria, according to new research.
Venezuela’s health crisis continues to abound and infectious diseases have been rising year after year to include measles, diphtheria, and malaria. The number of reported cases of malaria grew from 136,402 in 2015 to 240,613 in 2016 and 406,000 in 2017.
Scientists have developed a novel way with genome sequences to study and better understand transmission, treat and ultimately eradicate Plasmodium vivax, the most widespread form of malaria.
Unlike so-called ‘self-limiting’ genetic modification of mosquitoes – which, for example, renders them infertile or produce infertile offspring – gene drive works by unleashing a mutated gene that spreads rapidly through the species.
By developing a vaccine that targets specific cells in the immune system, researchers have seen a much greater immune and antibody response to the vaccine.
A type of mosquito that transmits malaria has been detected in Ethiopia for the first time, and the discovery has implications for putting more people at risk for malaria in new regions.